tiprankstipranks
Advertisement
Advertisement
BioRestorative Therapies price target lowered to $15 from $18 at Roth Capital
PremiumThe FlyBioRestorative Therapies price target lowered to $15 from $18 at Roth Capital
25d ago
BioRestorative Therapies reports blinded data from mesenchymal stem cells trial
Premium
The Fly
BioRestorative Therapies reports blinded data from mesenchymal stem cells trial
28d ago
Is BRTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is BRTX a Buy, Before Earnings?
1M ago
BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100
PremiumThe FlyBioRestorative completes patient enrollment in Phase 2 trial of BTRX-100
3M ago
BioRestorative Therapies files to sell 9.71M units
Premium
The Fly
BioRestorative Therapies files to sell 9.71M units
3M ago
BioRestorative Therapies files to sell 508,592 shares of common stock for holder
Premium
The Fly
BioRestorative Therapies files to sell 508,592 shares of common stock for holder
5M ago
BioRestorative Therapies Issues Regulation FD Disclosure
PremiumCompany AnnouncementsBioRestorative Therapies Issues Regulation FD Disclosure
6M ago
BRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
BRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
BioRestorative Therapies’ Promising Study on BRTX-100 for Lumbar Disc Disease
Premium
Company Announcements
BioRestorative Therapies’ Promising Study on BRTX-100 for Lumbar Disc Disease
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100